14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $33.24 $45.00 Wednesday, 24th Apr 2024 CRBP stock ended at $35.54. This is 5.83% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 11.97% from a day low at $34.24 to a day high of $38.34.
90 days $7.49 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Feb 17, 2021 $3.05 $3.05 $2.81 $2.90 16 354 913
Feb 16, 2021 $3.10 $3.16 $2.97 $3.05 20 270 420
Feb 12, 2021 $2.98 $3.33 $2.86 $2.99 28 610 726
Feb 11, 2021 $3.97 $4.00 $3.16 $3.34 53 706 089
Feb 10, 2021 $3.38 $3.60 $2.78 $3.42 66 263 335
Feb 09, 2021 $2.80 $3.31 $2.66 $3.08 50 563 961
Feb 08, 2021 $2.64 $2.85 $2.60 $2.80 12 910 699
Feb 05, 2021 $2.79 $2.82 $2.40 $2.69 17 371 048
Feb 04, 2021 $2.98 $3.00 $2.62 $2.72 28 164 670
Feb 03, 2021 $2.83 $3.04 $2.61 $2.69 48 708 332
Feb 02, 2021 $2.45 $2.80 $2.00 $2.58 65 617 060
Feb 01, 2021 $1.96 $2.26 $1.82 $2.23 21 936 247
Jan 29, 2021 $1.89 $2.01 $1.81 $1.83 6 868 880
Jan 28, 2021 $1.99 $2.06 $1.75 $1.85 8 967 840
Jan 27, 2021 $1.89 $2.17 $1.81 $1.95 13 702 945
Jan 26, 2021 $2.04 $2.06 $1.94 $1.97 7 453 128
Jan 25, 2021 $2.15 $2.18 $1.91 $2.02 11 261 043
Jan 22, 2021 $2.17 $2.23 $2.07 $2.11 12 849 885
Jan 21, 2021 $1.76 $2.36 $1.71 $2.36 40 767 878
Jan 20, 2021 $1.73 $1.76 $1.68 $1.74 5 857 033
Jan 19, 2021 $1.75 $1.80 $1.66 $1.73 5 469 507
Jan 15, 2021 $1.79 $1.86 $1.60 $1.74 11 773 237
Jan 14, 2021 $1.60 $1.79 $1.52 $1.74 13 017 716
Jan 13, 2021 $1.54 $1.67 $1.50 $1.61 12 578 480
Jan 12, 2021 $1.47 $1.55 $1.44 $1.50 8 438 818
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT